SIREN : 413400136
SYNERGIE SANTE is a French company founded 28 years ago, specialized in the sector Gestion de fonds. Based in PARIS (75008), this company of category GE shows in 2024 a revenue of 302 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-18
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 302 277 € | 300 034 € | 515 159 € | 470 369 € | 436 932 € | 417 218 € | 402 781 € | 314 050 € |
| Net income | 183 543 € | 188 058 € | 246 165 € | 197 498 € | 75 047 € | 43 001 € | -26 630 € | -71 080 € |
| EBITDA | 223 062 € | 191 182 € | 249 875 € | 160 704 € | -4 136 € | -46 974 € | -21 785 € | -68 674 € |
| Net margin | 60.7% | 62.7% | 47.8% | 42.0% | 17.2% | 10.3% | -6.6% | -22.6% |
In 2024, SYNERGIE SANTE achieves revenue of 302 k€. Activity remains stable over the period (CAGR: -0.5%). Vs 2023: +1%. After deducting consumption (0 €), gross margin stands at 302 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 223 k€, representing 73.8% of revenue. Positive scissor effect: EBITDA margin improves by +10.1 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 184 k€, i.e. 60.7% of revenue. This profit can be retained or distributed to shareholders.
302 277 €
302 277 €
223 062 €
223 063 €
183 543 €
73.8%
The debt ratio (= Financial debt / Equity x 100) stands at 176%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 34%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 5.6 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 60.7% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
176.21%
34.207%
60.72%
5.57
56.9%
In 2024, the debt ratio of SYNERGIE SANTE (176.21) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of SYNERGIE SANTE (34.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of SYNERGIE SANTE (5.57) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 1805.72. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 15.0x. Operating income very largely covers interest expenses: high safety margin.
1805.716
15.02
In 2024, the liquidity ratio of SYNERGIE SANTE (1805.72) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2024, the interest coverage of SYNERGIE SANTE (15.0x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 104 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 82 days. The company must finance 22 days of gap between collections and payments. Overall, WCR represents 1925 days of revenue, i.e. 1.6 M€ to permanently finance. Over 2017-2024, WCR increased by +367%, requiring additional financing.
1 616 154 €
104 j
82 j
0 j
1925 j
Based on 62 transactions of similar company sales
in 2024,
the value of SYNERGIE SANTE is estimated at
834 024 €
(range 257 744€ - 1 818 974€).
With an EBITDA of 223 062€, the sector multiple of 4.8x is applied.
The price/revenue ratio is 0.30x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 62 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare SYNERGIE SANTE with other companies in the same sector:
The revenue of SYNERGIE SANTE in 2024 is 302 k€.
Yes, SYNERGIE SANTE generated a net profit of 184 k€ in 2024.
The headquarters of SYNERGIE SANTE is located in PARIS (75008), in the department Paris.
The tax return of SYNERGIE SANTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
SYNERGIE SANTE operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.